Verition Fund Management LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 85 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,070,313
-36.9%
259,113
-31.2%
0.02%
-45.5%
Q2 2023$3,278,430
+128.7%
376,831
-22.7%
0.04%
+120.0%
Q1 2023$1,433,456
-26.3%
487,570
-12.2%
0.02%
-33.3%
Q4 2022$1,944,362
-56.5%
555,532
-50.8%
0.03%
-41.2%
Q3 2022$4,470,466
+5.7%
1,129,102
+110.0%
0.05%
-39.3%
Q2 2022$4,231,000
-23.8%
537,569
+17.6%
0.08%
+25.4%
Q1 2022$5,555,000
+43.5%
457,218
+44.6%
0.07%
+139.3%
Q4 2021$3,870,000316,1490.03%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,490,921$27,892,45924.59%
ACUTA CAPITAL PARTNERS, LLC 300,128$2,398,0231.61%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,492,147$27,902,2551.51%
Cormorant Asset Management, LP 3,200,000$25,568,0001.49%
Samsara BioCapital, LLC 432,000$3,451,6801.06%
Ghost Tree Capital, LLC 325,000$2,596,7500.85%
RA Capital Management 3,370,506$26,930,3430.53%
Ikarian Capital, LLC 4,487$3,585,1130.43%
Affinity Asset Advisors, LLC 155,000$1,238,4500.35%
SECTORAL ASSET MANAGEMENT INC 176,080$1,406,8790.27%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders